Cite
Hain E, Challine A, Tzedakis S, et al. Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial. Front Med (Lausanne). 2021;7:488doi: 10.3389/fmed.2020.00488.
Hain, E., Challine, A., Tzedakis, S., Mare, A., Martinino, A., Fuks, D., Adham, M., Piessen, G., Regimbeau, J. M., Buc, E., Barbier, L., Vaillant, J. C., Jeune, F., Sulpice, L., Muscari, F., Schwarz, L., Deguelte, S., Sa Cunha, A., Truant, S., Dousset, B., Sauvanet, A., & Gaujoux, S. (2020). Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial. Frontiers in medicine, 7488. https://doi.org/10.3389/fmed.2020.00488
Hain, Elisabeth, et al. "Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial." Frontiers in medicine vol. 7 (2020): 488. doi: https://doi.org/10.3389/fmed.2020.00488
Hain E, Challine A, Tzedakis S, Mare A, Martinino A, Fuks D, Adham M, Piessen G, Regimbeau JM, Buc E, Barbier L, Vaillant JC, Jeune F, Sulpice L, Muscari F, Schwarz L, Deguelte S, Sa Cunha A, Truant S, Dousset B, Sauvanet A, Gaujoux S. Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial. Front Med (Lausanne). 2021 Jan 15;7:488. doi: 10.3389/fmed.2020.00488. eCollection 2020. PMID: 33521003; PMCID: PMC7844059.
Copy
Download .nbib